Easy synergism for colistin-resistant KPC-producing Klebsiella pneumoniae: the E-test with supplemented agar E. Tagliaferri, C. Tascini, A. Leonildi,

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Antimicrobial susceptibility testing of colistin – evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli,

Spread of KPC-producing carbapenem-resistant Enterobacteriaceae: the importance of super-spreaders and rectal KPC concentration A. Lerner, A. Adler,

Gut bacterial microbiota and obesity

I.J. Schalk Clinical Microbiology and Infection

I. López-Hernández, M. Delgado Valverde, N. Batista Díaz, A. Pascual

O.J. Dyar, G. Tebano, C. Pulcini Clinical Microbiology and Infection

D. Khalil, M. Hultin, M.U. Rashid, B. Lund

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources N. Singh,

Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis T. Steinmetz, N.

Herpes zoster in non-hospitalized children

In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin- resistant Acinetobacter baumannii X. Vila-Farres, C. Garcia.

Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications T.-L. Liao, Y.-M.

Migrant health—a cause for concern?

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Cross-resistance to human cationic antimicrobial peptides and to polymyxins mediated by the plasmid-encoded MCR-1? J. Dobias, L. Poirel, P. Nordmann

Refugee crisis and re-emergence of forgotten infections in Europe

Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries J.A. Otter, N.T. Mutters, E. Tacconelli, A.

A. F. Simonetti, C. Garcia-Vidal, D. Viasus, D. García-Somoza, J

P. Nordmann, L. Poirel Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

Extended-spectrum β-lactamase/AmpC- and carbapenemase-producing Enterobacteriaceae in animals: a threat for humans? J.-Y. Madec, M. Haenni, P. Nordmann,

Risk factors and outcome for colistin-resistant Acinetobacter nosocomialis bacteraemia in patients without previous colistin exposure Y.-C. Wang, Y.-T.

Dermatitis by Dermatophilus congolensis

Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice? T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt

H. Adibhesami, M. Douraghi, M. Rahbar, A. Abdollahi

Vector control: a cornerstone in the malaria elimination campaign

Do we need new antibiotics?

Training for the infectious diseases speciality in Norway

Unveiling the molecular basis of antimicrobial resistance in Staphylococcus aureus from the Democratic Republic of the Congo using whole genome sequencing

Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman Clinical.

Early invasive fungal infections and colonization in patients with cirrhosis admitted to the intensive care unit E. Theocharidou, B. Agarwal, G. Jeffrey,

Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aureus infections—a systematic review and meta-analysis R. Diaz, V. Afreixo,

Levofloxacin in the treatment of ventilator-associated pneumonia

R. Bitterman, M. Paul, D. Polak, Y. Geffen

A. Potron, J. Kalpoe, L. Poirel, P. Nordmann

Metagenomics and probiotics

M. Aires-de-Sousa Clinical Microbiology and Infection

W. -L. Yu, M. -F. Lee, H. -J. Tang, M. -C. Chang, J

Previously unknown species of Aspergillus

J. Garau Clinical Microbiology and Infection

T.M. File Clinical Microbiology and Infection

Sexually acquired Zika virus: a systematic review

Systematic review of antibiotic consumption in acute care hospitals

Abstracts cont. Clinical Microbiology and Infection

Vaccinations against respiratory tract infections at Hajj

C. Tamalet, P. Colson, E. Decroly, C. Dhiver, I. Ravaux, A. Stein, D

Relationship between the early Boceprevir-S isomer plasma concentrations and the onset of breakthrough during HCV genotype 1 triple therapy L. Boglione,

S. M. Bartsch, J. A. McKinnell, L. E. Mueller, L. G. Miller, S. K

Dynamics of hepatitis B virus quasispecies heterogeneity in association with nucleos(t)ide analogue treatment determined by MALDI-TOF MS M. Rybicka,

Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013 U. Fedeli, E. Schievano,

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems? G.L. Daikos, A. Markogiannakis Clinical Microbiology.

Bactericidal and synergistic activity of double-carbapenem regimen for infections caused by carbapenemase-producing Klebsiella pneumoniae A. Oliva, F.

Overview of cefixime use in community-acquired infections

M.T. Pérez-Rodríguez, A. Sousa, P. Martínez-Cueto, A. Ocampo

Survival of rhinoviruses on human fingers

The atypical pneumonias: clinical diagnosis and importance

Virology: a scientific discipline facing new challenges

Modelling during an emergency: the 2009 H1N1 influenza pandemic

R. Khatib, G. Simeunovic, M. Sharma, M. G. Fakih, L. B. Johnson, L

Are we losing the fight against malaria one more time?

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

CMI readers' survey Clinical Microbiology and Infection

Rajko Saletinger, Mario Poljak, Franc Strle

The future of diagnostic bacteriology

Presentation transcript:

Easy synergism for colistin-resistant KPC-producing Klebsiella pneumoniae: the E-test with supplemented agar E. Tagliaferri, C. Tascini, A. Leonildi, I. Ciullo, F. Amadori, F. Menichetti Clinical Microbiology and Infection Volume 21, Issue 2, Pages e7-e8 (February 2015) DOI: 10.1016/j.cmi.2014.08.016 Copyright © 2014 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

FIG. 1 Minimum inhibitory concentrations of colistin on Mueller-Hinton agar alone (left) and supplemented with rifampin 32 mg/L (right) against Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae (KPC-Kp). Clinical Microbiology and Infection 2015 21, e7-e8DOI: (10.1016/j.cmi.2014.08.016) Copyright © 2014 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions